Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact Fensolvi® delivers an all-in-one treatment experience for children with central precocious puberty (CPP). 6-month dosing Subcutaneous injection Leuprolide acetate Comprehensive patient support FENSOLVI (leuprolide acetate) for injectable suspension is a gonadotropin releasing hormone (GnRH) agonist used to treat patients 2 years of age and older with central precocious puberty (CPP). CPP may be diagnosed when signs of sexual maturity begin to develop in girls under the age of 8 or in boys under the age of 9. IMPORTANT SAFETY INFORMATION FENSOLVI is contraindicated in individuals with hypersensitivity to any drug that is in the same class as FENSOLVI, in individuals who are allergic to any of the ingredients in FENSOLVI, or in individuals who are pregnant. FENSOLVI may cause fetal harm when administered to a pregnant patient. Please see Full Prescribing Information for additional important safety information. Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top

Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact Resources Empowering Patients and the Community through Education Explore Tolmar’s educational resources. *These links will take you to the websites of other organizations. Tolmar is not responsible for the content on these sites. CDC - Prostate Cancer American Cancer Society National Comprehensive Cancer Network Urology Care Foundation Clinical Trials – Learn about ongoing clinical trials to determine if one is right for you. The Prostate Cancer Clinical Trials Consortium ClinicalTrials.gov Prostate Cancer Advocacy Groups – Find information, support and ways to get involved in the fight against prostate cancer. ZERO – The End of Prostate Cancer Prostate Cancer Research Institute Prostate Health Education Network Prostate Cancer Foundation Us TOO Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top